Senate Hearing on Biotech: Innovation, Regulation, and Access

The Power of Biotech Innovation

• 💡 American innovation has transformed medicine, eradicating diseases that were once common and debilitating.
• 🚀 Examples include the rapid decline of measles cases after vaccine introduction and the shift from stomach surgery to medication for peptic ulcers.
• ✨ Modern advancements include treatments for obesity, Alzheimer's, hepatitis C, and 3D-printed spinal implants.
• 📈 The US leads in biotech patents, producing twice as many novel products as European countries, with the FDA's gold standard review.

Challenges to Maintaining US Leadership

• ⚠️ Regulatory uncertainty and outdated frameworks stifle progress and encourage developers to move overseas.
• 🇨🇳 China is viewed as a collaborator, competitor, and threat, rapidly increasing its clinical trial participation and global drug pipeline share.
• 📉 Developers are looking outside the US for early-stage clinical work, necessitating a stronger domestic approach.
• ⚙️ Structural reforms are needed to provide innovators stability and confidence, including eliminating unnecessary FDA barriers while maintaining review standards.

The Critical Issue of Drug Affordability

• 💊 High prescription drug costs prevent one in four Americans from affording their prescribed medications, leading to suffering and increased healthcare system expenses.
• 💰 Examples of price disparities include Keytruda, Darillex, and Opdivo, which are significantly more expensive in the US than in Germany, Japan, or Canada.
• 📈 The median price of new drugs has more than doubled in recent years, driven by pharmaceutical industry lobbying and high CEO compensation.
• 📉 Top pharmaceutical companies made over $100 billion in profits last year, while millions of Americans struggle to afford necessary medications.

Modernizing Regulatory Processes and Innovation

• 🤖 Leveraging AI and machine learning can accelerate drug discovery and clinical development, making reviews more efficient and predictable.
• 🔬 FDA can facilitate the use of advanced evidence generation techniques, such as innovative trial designs and real-world data.
• 🌍 Updating regulations can make the US more globally competitive, particularly in manufacturing and early-phase clinical research.
• 🤝 Collaboration between innovators and government is crucial to maintain US leadership in biotechnology.

The Role of Public Funding and Access

• 💰 Public research funding, particularly through the NIH, is a primary driver of biotechnology innovation, catalyzing the development of life-saving treatments.
• 📉 Cuts to NIH funding threaten the discovery of new treatments and the US scientific establishment.
• ⚖️ Reasonable drug prices are essential for patient access, with the Inflation Reduction Act offering a mechanism for Medicare to negotiate prices.
• 🩺 Ensuring adequate insurance coverage, including through Medicaid and ACA marketplaces, is vital for patients to access these innovations.